Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms (Q37812457)

23 August 2017

Anticytokine autoantibodies in infectious diseases: pathogenesis and mechanisms (English)

1 reference

23 August 2017

0 references

1 reference

Sarah K Browne

1

1 reference

PubMed ID

21109174

23 August 2017

Steven M Holland

series ordinal

2

1 reference

23 August 2017

1 December 2010

1 reference

Lancet Infectious Diseases

23 August 2017

1 reference

23 August 2017

10

1 reference

23 August 2017

12

1 reference

23 August 2017

875-885

1 reference

Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-IL-8 autoantibodies and complexes in rheumatoid arthritis: polyclonal activation in chronic synovial tissue inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Beneficial autoimmunity to proinflammatory mediators restrains the consequences of self-destructive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Spontaneous neutralising antibodies to interferon--alpha and interleukin-12 in thymoma-associated autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-cytokine autoantibodies in autoimmunity: preponderance of neutralizing autoantibodies against interferon-alpha, interferon-omega and interleukin-12 in patients with thymoma and/or myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Spontaneous production of anti-IFN-alpha and anti-IL-12 autoantibodies by thymoma cells from myasthenia gravis patients suggests autoimmunization in the tumor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Circulating IL-8 and anti-IL-8 autoantibody in patients with ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Antibodies to human leucocyte interferons in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Antibodies to interferon (IFN) in hepatitis C patients relapsing while continuing recombinant IFN-alpha2 therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Development of neutralizing antibodies in patients with relapsing-remitting multiple sclerosis treated with IFN-beta1a.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Natural antibodies to interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-interleukin-6 antibodies in normal human serum

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Autoantibodies to crude human leucocyte interferon (IFN), native human IFN, recombinant human IFN-alpha 2b and human IFN-gamma in healthy blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

The Detection and Biological Activity of Human Antibodies to IL-2 in Normal Donors

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-cytokine autoantibodies are ubiquitous in healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Autoantibodies against erythropoietin in a patient with pure red-cell aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Granulocyte colony-stimulating factor and neutrophils--forgotten mediators of inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Lungs of patients with idiopathic pulmonary alveolar proteinosis express a factor which neutralizes granulocyte-macrophage colony stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Idiopathic pulmonary alveolar proteinosis as an autoimmune disease with neutralizing antibody against granulocyte/macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Serological diagnosis of idiopathic pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

BAL findings in a patient with pulmonary alveolar proteinosis successfully treated with GM-CSF

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Surfactant protein-A concentration in bronchoalveolar lavage fluids of patients with pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Cure of brain abscess caused by Nocardia asteroides resistant to multiple antibiotics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

NOCARDIOSIS AND PULMONARY ALVEOLAR PROTEINOSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Primary cerebellar nocardiosis and alveolar proteinosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis with systemic nocardiosis. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

THE ASSOCIATION OF NOCARDIOSIS AND PULMONARY ALVEOLAR PROTEINOSIS. A CASE STUDY.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis and nocardiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Cerebellar aspergilloma.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis with unusual complicating infections; a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary Alveolar Proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis and pulmonary cryptococcosis in an adolescent boy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

STAT3 mutations in the hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Recurrent staphylococcal cellulitis and subcutaneous abscesses in a child with autoantibodies against IL-6.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Interleukin-8: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-IL-8 autoantibodies in alveolar fluid from patients at risk for ARDS and with well-defined ARDS

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-interleukin 8 autoantibody: interleukin 8 complexes in the acute respiratory distress syndrome. Relationship between the complexes and clinical disease activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Elevation of IL-12 p40 and its antibody in myasthenia gravis with thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Mutations in STAT3 and IL12RB1 impair the development of human IL-17-producing T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Human dectin-1 deficiency and mucocutaneous fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

A homozygous CARD9 mutation in a family with susceptibility to fungal infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-cytokine autoantibodies are associated with opportunistic infection in patients with thymic neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

IL-22: a critical mediator in mucosal host defense

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

IL-22 increases the innate immunity of tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Characteristics of autoantibodies to human interferon in a patient with varicella-zoster disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Interferon-gamma and interleukin-12 pathway defects and human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-IFN-gamma autoantibodies in disseminated nontuberculous mycobacterial infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Autoantibodies to interferon-gamma in a patient with selective susceptibility to mycobacterial infection and organ-specific autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Acquired predisposition to mycobacterial disease due to autoantibodies to IFN-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Disseminated Mycobacterium avium complex infection in a patient with autoantibody to interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-interferon-gamma autoantibody in a patient with disseminated Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Crohn's disease: a review of current treatment with a focus on biologics.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Auto-antibodies to tumour necrosis factor alpha in healthy humans and patients with inflammatory diseases and gram-negative bacterial infections.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

GM-CSF regulates alveolar macrophage differentiation and innate immunity in the lung through PU.1.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

The molecular basis of pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Secondary alveolar proteinosis in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis: progress in the first 44 years

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis. Further evaluation of abnormal alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Defective Lung Macrophages in Pulmonary Alveolar Proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

GM-CSF regulates protein and lipid catabolism by alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Isolation of mycobacteria in patients with pulmonary alveolar proteinosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis and histoplasmosis: report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

GM-CSF autoantibodies and neutrophil dysfunction in pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Pulmonary alveolar proteinosis and Nocardia brain abscess. Report of a case.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

The cerebral complications of pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Molecular biology of erythropoietin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Disseminated nontuberculous mycobacterial infection in patients who are not infected with HIV in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Disseminated infection due to rapidly growing mycobacteria in immunocompetent hosts presenting with chronic lymphadenopathy: a previously unrecognized clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Infections with rapidly growing mycobacteria: report of 20 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Disease caused by non-tuberculous mycobacteria in a university hospital in Taiwan, 1997-2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Emergence of disseminated infections due to nontuberculous mycobacteria in non-HIV-infected patients, including immunocompetent and immunocompromised patients in a university hospital in Taiwan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Projection of an immunological self shadow within the thymus by the aire protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

APS-I/APECED: the clinical disease and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Molecular characterization of the human interleukin (IL)-17 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

The role of T-cells in the initiation of autoantibody responses in thymoma patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Autoantibodies to IL-12 in myasthenia gravis patients with thymoma; effects on the IFN-gamma responses of healthy CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Thymoma, myasthenia gravis, and other paraneoplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Myasthenia gravis with thymoma and pure red blood cell aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Thymoma-associated systemic lupus erythematosus, exacerbating after thymectomy. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Graft-versus-host-like disease complicating thymoma: lack of AIRE expression as a cause of non-hereditary autoimmunity?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

What is Good's syndrome? Immunological abnormalities in patients with thymoma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

The role of plasmacytoid dendritic cell-derived IFN alpha in antiviral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

G-CSF: a key regulator of neutrophil production, but that's not all!

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Clinical and Serologic Observations on 27 Patients with Felty's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Osteoporosis Associated with Neutralizing Autoantibodies against Osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Exogenous granulocyte-macrophage colony-stimulating factor administration for pulmonary alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Recurrent, multifocal Mycobacterium avium-intercellulare infection in a patient with interferon-gamma autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

A peptide-based erythropoietin-receptor agonist for pure red-cell aplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Sustained response to Rituximab in anti-AChR and anti-MuSK positive Myasthenia Gravis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Rituximab therapy in autoimmune pulmonary alveolar proteinosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Increased levels of antibodies to IFN-gamma in human and experimental African trypanosomiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Correlation of subclasses of IgG with disease activity in pemphigus vulgaris.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Correlation of peptide specificity and IgG subclass with pathogenic and nonpathogenic autoantibodies in pemphigus vulgaris: a model for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Characterization and potential clinical applications of autoantibodies against cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

An anti-IL-2 antibody increases serum half-life and improves anti-tumor efficacy of human recombinant interleukin-2

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Selective stimulation of T cell subsets with antibody-cytokine immune complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-cytokine autoantibodies explain some chronic mucocutaneous candidiasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

Anti-receptor antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970196-1

7 January 2021

10.1016/S1473-3099(10)70196-1

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21109174